Skip to main navigation Skip to search Skip to main content

An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer's disease

  • Hanna Rosenmann*
  • , Zeev Meiner
  • , Esther Kahana
  • , Zoja Aladjem
  • , Gideon Friedman
  • , Arie Ben-Yehuda
  • , Tal Grenader
  • , Eli Wertman
  • , Oded Abramsky
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Recent studies have demonstrated that p53-associated apoptosis is involved in the pathogenesis of Alzheimer's disease (AD). We performed a case-control association study between sporadic AD and the common proline/arginine polymorphism at codon 72 in the pro-apoptotic gene p53, in 109 sporadic AD patients and in 111 controls. This polymorphism has been intensively investigated for association with cancer, but so far not with AD and neurodegeneration. We found no association between this locus and the risk for AD. No association was detected also for the age at disease onset and for disease progression, and no interactive effect was found with apolipoprotein E e4. These findings show no evidence for an association between p53 codon 72 polymorphism and AD in our population.

Original languageEnglish
Pages (from-to)29-32
Number of pages4
JournalNeuroscience Letters
Volume340
Issue number1
DOIs
StatePublished - 3 Apr 2003
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Alzheimer's disease
  • Apoptosis
  • Association study
  • Polymorphism
  • p53

Fingerprint

Dive into the research topics of 'An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer's disease'. Together they form a unique fingerprint.

Cite this